SCHEMBL21923950

SCHEMBL21923950

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(c4)-c4ccccc4C54c5ccccc5C(c5ccccc5)(c5ccccc5)c5ccccc54)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
OPRK1 P41145 1/20 0.39
PDK2 Q15119 2/20 0.35
APAF1 O14727 1/20 0.32
NPC1 O15118 1/20 0.32
THRB P10828 1/20 0.32
XBP1 P17861 1/20 0.32
PTBP1 P26599 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
GALK1 P51570 1/20 0.32
BLM P54132 1/20 0.32
SMAD3 P84022 1/20 0.32
ATM Q13315 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21923990 0.95 KDM4E (0.39) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21923882 0.95 MAPT (0.42) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21923933 0.95 MAPT (0.42) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21559459 0.93 MAPT (0.41) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21924582 0.93 MAPT (0.41) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL25496140 0.93 PDK2 (0.39) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL20710355 0.93 PDK2 (0.39) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL20710331 0.93 PDK2 (0.39) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL20710342 0.93 MEN1 (0.35) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL21923899 0.92 MAPT (0.39) MEN1LMNAMAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3567026-B1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME LG CHEMICAL LTD (KR) 2021-12-29 EP disclosed
US-20200131112-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131112-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME AOX1, CYP1B1, CRY1 MEN1 558/4885LMNA 4312/4885MAPT 2292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.